Join the club for FREE to access the whole archive and other member benefits.

Novocure

Treating solid tumor cancers

Novocure's logo represents a global company pioneering Tumor Treating Fields (TTFields) therapy, an innovative cancer treatment that uses electric fields to target and kill cancer cells. This therapy is designed to complement traditional cancer treatments, providing a new, versatile option for solid tumor treatment. Research shows TTFields therapy can be used in combination with other cancer therapies, enhancing its effectiveness. Novocure's ongoing clinical trials and preclinical research explore its potential across various tumor types. Novocure also provides resources for patients and healthcare professionals, offering educational materials on TTFields therapy and its mechanisms.

Visit website: https://www.novocure.com/

 novocure-inc

 Novocure

 UCuzA71KFInZJKm9B24mBJZQ

Details last updated 17-Oct-2024

Novocure News

Wearable cancer device kills lung cancer cells with electrical fields

Wearable cancer device kills lung cancer cells with electrical fields

MedCity News - 16-Oct-2024

The technology extends survival for some patients by 3.3 months

Novocure received European approval for its Tumor Treating Fields therapy

Novocure received European approval for its Tumor Treating Fields therapy

FierceBiotech - 11-Nov-2022

This expansion follows earlier FDA approval in the U.S. With financing from JPMorgan